Patent: 9,750,793
✉ Email this page to a colleague
Summary for Patent: 9,750,793
Title: | Multifunctional oral vaccine based on chromosome recombineering |
Abstract: | A recombineered Salmonella typhi Ty21a, compositions and vaccines comprising such a Ty21a, and a method for recombineering comprising inserting a large antigenic region into a bacterial chromosome for the purpose of making multivalent vaccines to protect against one or more disease agents are described herein. |
Inventor(s): | Dharmasena; Madushini Nirosha (Germantown, MD), Kopecko; Dennis J. (Silver Spring, MD) |
Assignee: | The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) |
Application Number: | 14/428,870 |
Patent Claims: | see list of patent claims |
Details for Patent 9,750,793
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emergent Travel Health, Inc. | VIVOTIF | typhoid vaccine live oral ty21a | Capsule | 103123 | 12/15/1989 | ⤷ Try a Trial | 2032-09-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |